EQS-Adhoc: HBM-Portfoliounternehmen Valo Health und Khosla Ventures Acquisition | Newsticker fuw.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fuw.ch Daily Mail and Mail on Sunday newspapers.
Valo Health Receives $110 Million In Funding From Koch Disruptive Technologies To Close Series B
Valo s CEO To Provide Insights On Programs And Opal Platform At Barclays Global Healthcare Conference
News provided by
Share this article
Share this article
BOSTON, March 9, 2021 /PRNewswire/ Valo Health LLC (Valo), a technology company transforming the drug discovery and development process and seeking to accelerate the creation of life-changing drugs, today announced the final closing of its Series B at $300 million, including a $110 million investment from Koch Disruptive Technologies (KDT). This brings the overall funding of Valo to over $450 million.
With this investment Valo will continue to scale its Opal Computational Platform